Which Countries Have Legalized Cannabis?

International cannabis legalization has accelerated significantly, creating a patchwork of regulatory frameworks around the world. Understanding the global landscape is important for investors, as several publicly traded cannabis companies operate across multiple international markets.

Canada was the first G7 nation to legalize adult-use cannabis nationwide in October 2018 under the Cannabis Act. The Canadian market includes major licensed producers (LPs) like Tilray, Canopy Growth, and Aurora Cannabis, many of which are publicly traded on the TSX and US exchanges. However, the Canadian market has struggled with oversupply, regulatory restrictions on marketing and retail formats, and competition from the legacy (illicit) market, leading to significant financial losses for many LPs.

In Europe, Germany became the largest country in the EU to legalize adult-use cannabis in 2024, with a framework emphasizing personal cultivation, cannabis social clubs, and plans for a regional pilot of commercial retail sales. The Netherlands has operated its famous "coffee shop" tolerance policy for decades, though commercial cultivation remained illegal until recent pilot programs. Other European countries including Luxembourg, Malta, and the Czech Republic have moved toward legalization, while many others maintain medical-only programs.

Uruguay was the first country in the world to fully legalize cannabis in 2013, operating a government-regulated market with pharmacy sales, cannabis clubs, and home cultivation. In Latin America and the Caribbean, Mexico has been moving toward legalization through court rulings, and several Caribbean nations have decriminalized or legalized cannabis. In Africa, countries like South Africa, Lesotho, and Morocco are developing cannabis industries primarily focused on medical and export markets.

For cannabis investors, international markets represent both opportunity and risk. Companies like Tilray, Organigram, and Curaleaf have operations spanning North America and Europe. The total addressable market expands significantly as more countries adopt legal frameworks. However, international cannabis operations face challenges including varying regulatory standards, import/export restrictions, currency risk, political instability, and the high cost of maintaining compliance across multiple jurisdictions. The European medical cannabis market is generally viewed as the most attractive near-term international opportunity due to established healthcare infrastructure and reimbursement systems.